Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (5901)	1/18/1999 7:14:00 PM
From: Izzy	Read Replies (1) \| Respond to of 6136

According to IR, 1-27-99 at 5 PM. Apparently fax info was sent to some people, but not to me. Does anyone out there have a copy of the fax report that they can post?

To: Izzy who wrote (5901)	1/24/1999 10:19:00 PM
From: Prentiss Hallenbeck	Read Replies (1) \| Respond to of 6136

Been gone two weeks. Elise only gives out name, rank & serial number. If all comes true, should have some action in AGPH this week. Before reporting they will set up new corp. structure (i.e. Oncoceutics). On a pro forma basis they will report $1.23 for '98 vs previous projections of $0.85. I don't know if they will restate for fiscal '98 or not. Now that viracept is leading PI, they are trying to build a complete package of HIV products: Remune, reverse transcriptase inhibitor and 2nd generation viracept. Remember you need a second big drug before market really takes off, i.e. GNE & AMGN. Both the macular and rhino are in phase study. Last but not least, I have a granddaughter named Elise and she is 1/2 Chinese. Nough said. Prenth